(1) Genovese MC, Becker J-C, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor Î inhibition, N Engl J Med. 2005;353:1114-1123.
(2) Simon T, poster presentation at EULAR 2006.
(3) http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-SF-07-0... accessed 25-04-07.
(4) http://ec.europa.eu/health/ph_informatio... accessed 25-04-07.
Media Contact: Brian Henry, Bristol-Myers Squibb, Office: +33-1-58-83-69-38, Mobile: +33-6-75-09-08-99, brian.henry@bms.com
